Why the study?
Does the presence of preformed anti-HLA antibodies increase the risk of antibody-mediated rejection and cardiac allograft vasculopathy in heart transplant recipients?
Does the presence of preformed anti-HLA antibodies increase the risk of antibody-mediated rejection and cardiac allograft vasculopathy in heart transplant recipients?
Answers are grounded in this paper and cite their sources.
The presence of preformed anti-HLA antibodies in heart transplant candidates significantly increases the risk of antibody-mediated rejection and cardiac allograft vasculopathy.
Aim. The aim of this study was to de fi ne the role of preformed anti-HLA antibodies (anti-HLA) in antibody-mediated rejection (AMR) and cardiac allograft vasculopathy (CAV) after heart transplantation. Materials and Methods. 140 heart transplant recipients were followed after heart transplantation performed for 106 dilated and 34 – ischemic cardiomyopathy. Anti-HLA was determined before transplantation by ELISA. Results. Recipients were divided into 2 groups: anti-HLA positive (n = 45, 32,1%) and anti-HLA negative (n = 95, 67,9%). The incidence of AMR in anti-HLA positive group was 12 (26,67%) and 11 (11,58%) in anti-HLA negative group. Risk of AMR was signi fi cantly higher in anti-HLA positive recipients (RR 2,3: 95% CI 1,02–4,81, р = 0,03). During fi rst three years after transplantation CAV was diagnosed in 9 (20%) of anti-HLA positive recipients and in 7 (6,8%) of patients without anti-HLA. (RR 2,7: 95% CI 1,08–6,82, р = 0,03). Survival in freedom from CAV in anti-HLA negative recipients was much higher than in anti-HLA positive recipients (0,89 ± 0,07, 0,72 ± 0,06, resp. (p = 0,02)). Conclusions. The presence of preformed anti-HLA antibodies in candidates for heart transplantation increase the risk of AMR and CAV post transplantation in 2,3 and 2,7 times, respectively.
No takes yet. Share an insight, caveat, or question.
Shevchenko et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: